ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,187 | $793 | $396 | $570 |
| - Cash | $50 | $76 | $49 | $59 |
| + Debt | $0 | $3 | $3 | $9 |
| Enterprise Value | $1,138 | $720 | $350 | $520 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$32 | -$39 | -$32 | -$36 |
| % Margin | – | – | – | – |
| Net Income | -$33 | -$36 | -$30 | -$36 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.33 | -0.47 | -0.42 | -0.51 |
| % Growth | 29.8% | -11.9% | 17.6% | – |
| Operating Cash Flow | -$25 | -$31 | -$33 | -$28 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$25 | -$31 | -$33 | -$28 |